Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NitrO Systems is a medical technology company specializing in the controlled delivery of nitric oxide for therapeutic applications. The company's platform technology is designed to provide a sustained and localized release of nitric oxide, which possesses potent antimicrobial and vasodilatory properties. Their primary focus is on treating chronic, non-healing wounds such as diabetic foot ulcers, where nitric oxide can promote healing and reduce infection. NitrO Systems is a spin-off from the University of Nebraska-Lincoln and continues to advance its pipeline through pre-clinical studies. The company aims to provide a more effective and user-friendly alternative to existing nitric oxide therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NitrOSystems.